APA (7th ed.) Citation

Shinnakasu, R., Sakakibara, S., Yamamoto, H., Wang, P., Moriyama, S., Sax, N., . . . Kurosaki, T. (2021). Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses. The Journal of experimental medicine, 218(12), . https://doi.org/10.1084/jem.20211003

Chicago Style (17th ed.) Citation

Shinnakasu, Ryo, et al. "Glycan Engineering of the SARS-CoV-2 Receptor-binding Domain Elicits Cross-neutralizing Antibodies for SARS-related Viruses." The Journal of Experimental Medicine 218, no. 12 (2021). https://doi.org/10.1084/jem.20211003.

MLA (9th ed.) Citation

Shinnakasu, Ryo, et al. "Glycan Engineering of the SARS-CoV-2 Receptor-binding Domain Elicits Cross-neutralizing Antibodies for SARS-related Viruses." The Journal of Experimental Medicine, vol. 218, no. 12, 2021, https://doi.org/10.1084/jem.20211003.